Recent Company News

• 11:00 PM ET Aug 20, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (113 total)

• 12:15 AM ET Aug 20, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (81 total)

• 11:11 PM ET Aug 19, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (47 total)

• 02:46 AM ET Aug 05, 2025
  

  Medipal Holdings reports Q1 net income attributable ¥9.59B vs FactSet ¥8.78B [2 est, ¥8.49-9.08B] (¥2552.5000, 0)

• 02:38 AM ET Jun 24, 2025
  

  European Commission grants orphan drug registration to JCR Pharmaceuticals and Medipal Holdings's JR-446 for MPS IIIB (¥518.0000, 0)

• 02:37 AM ET May 23, 2025
  

  Medipal Holdings president and CEO Shuichi Watanabe is undergoing medical treatment (¥2264.5000, 0)

• 11:59 PM ET May 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:44 PM ET May 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:52 AM ET May 13, 2025
  

  Medipal Holdings reports FY net income attributable ¥40.28B vs guidance ¥33.50B and FactSet ¥44.39B [3 est, ¥39.82-47.35B] (¥2478.5000, 0)

• 02:44 AM ET May 07, 2025
  

  JCR Pharmaceuticals receives FDA's orphan drug destination for JR-446 for mucopolysaccharidosis type IIIB (¥483.0000, 0)